Management of unspecified anxiety disorder: Expert consensus.

ABSTRACT:

Aims

Treatment guidelines with respect to unspecified anxiety disorder have not been published. The aim of this study was to develop a consensus among field experts on the management of unspecified anxiety disorder.

Methods

Experts were asked to evaluate treatment choices based on eight clinical questions concerning unspecified anxiety disorder using a nine-point Likert scale (1 = "disagree" to 9 = "agree"). According to the responses from 119 experts, the choices were categorized into first-, second-, and third-line recommendations.

Results

Benzodiazepine anxiolytic use was not categorized as a first-line recommendation for the primary treatment of unspecified anxiety disorder, whereas multiple nonpharmacological treatment strategies, including coping strategies (7.9

SUBMITTER: Sakurai H 

PROVIDER: S-EPMC10275278 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature